The Autologous CaTeVac Dendritic Cell Vaccine in Patients with Melanoma: Final Results of the DENDRON-01 Study. (2025). Voprosy Onkologii, 71(4), OF-2437. https://doi.org/10.37469/0507-3758-2025-71-4-OF-2437